NEW YORK (GenomeWeb) – Roche said today that its diagnostics revenues grew 5 percent year over year for the first quarter of 2018, driven by growth across the entire Dx division.

For the three months ended March 31, the Swiss pharmaceutical and diagnostics company reported overall revenues of CHF 13.58 billion ($13.85 billion), up 5 percent from CHF 12.94 billion in Q1 2017.

In diagnostics, Roche reported revenues of CHF 2.91 billion, up from CHF 2.77 billion in 2017.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.